CVE-2023-6078 — An OS Command Injection vulnerability exists in BIOVIA Materials Studio products

An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.

01What is this vulnerability?

An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.

02Affected products

Vendor	Product	Versions
Dassault Systèmes	BIOVIA Materials Studio products	BIOVIA 2021 Golden, BIOVIA 2022 Golden, BIOVIA 2023 Golden

03Active exploitation status

Not currently listed on the CISA Known Exploited Vulnerabilities (KEV) catalog. EPSS is the best forward-looking signal — see the EPSS row above.

04Recommended remediation

• Patch to a fixed version listed in the vendor advisory (see references below).
• Mitigate with WAF rules, network egress filters, or feature flags where the patch is not yet available.
• Hunt historical logs for exploitation indicators — see Detection signatures below.

05Technical details

For the full vendor write-up, exploit chains, and reference implementations, see the references list in section 09.

06Detection signatures

Ask SARA in chat to draft a starting detection for this CVE in your stack of choice.

07Related CVEs

No directly-cited follow-up CVEs in the KB record for this advisory. The references list in section 09 carries the vendor cross-references.

08Timeline

• Published: 2024-02-01T13:33:48.731Z
• Last modified: 2025-06-09T20:37:52.984Z

09References

• www.3ds.com — https://www.3ds.com/vulnerability/advisories